SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 37 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,984,976 | +4.7% | 5,082,000 | 0.0% | 0.04% | -4.8% |
| Q2 2023 | $8,580,143 | -37.4% | 5,082,000 | -28.2% | 0.04% | -39.1% |
| Q1 2023 | $13,695,632 | -24.7% | 7,080,000 | -51.2% | 0.07% | -22.5% |
| Q2 2022 | $18,198,000 | -4.5% | 14,500,000 | 0.0% | 0.09% | +71.2% |
| Q1 2022 | $19,049,000 | – | 14,500,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 82,499,000 | $120,618,000 | 3.75% |
| WOLVERINE ASSET MANAGEMENT LLC | 76,497,000 | $112,118,000 | 1.04% |
| Verition Fund Management LLC | 24,689,000 | $36,219,000 | 0.26% |
| Baker Brothers Advisors | 29,174,000 | $42,695,000 | 0.21% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 6,858,000 | $10,032,000 | 0.17% |
| LORD, ABBETT & CO. LLC | 48,435,000 | $71,054,000 | 0.16% |
| Calamos Advisors LLC | 21,131,000 | $30,817,000 | 0.12% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,218,000 | $4,726,000 | 0.10% |
| Point72 Asset Management, L.P. | 9,507,000 | $13,948,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 10,000,000 | $14,609,000 | 0.05% |